We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Respiratory Syncytial Virus Inhibits a Critical Lung Anti-Inflammatory Protein

By LabMedica International staff writers
Posted on 23 Mar 2011
Respiratory syncytial virus (RSV), a major cause of lower respiratory tract infections in children, damages lung tissue by inducing reactive oxygen species (ROS) while inhibiting a protein that would otherwise trigger a massive anti-inflammatory response to prevent oxidative injury in the lungs.

Investigators at the University of Texas Medical Branch (Galveston, USA) analyzed tissues from children with RSV infections as well as results from experiments conducted on mice. More...
They reported in the March 4, 2011, online edition of the American Journal of Respiratory and Critical Care Medicine that Nrf2 (nuclear factor (erythroid-derived 2)-like 2) expression was significantly reduced in the children's lung tissue and in the lungs of viral infected mice. Reduction in Nrf2 activity induced a significant decrease in the expression and/or activity of SOD (superoxide dismutase), catalase, GST (glutathione S-transferase), and GPx (glutathione peroxidase). Furthermore, markers of oxidative damage correlated with severity of clinical illness in RSV-infected infants.

Nrf2 is a transcription factor, which in humans is encoded by the NFE2L2 gene. Nrf2 is a master regulator of the antioxidant response, which is important for the amelioration of oxidative stress. Oxidative stress can result in cancer, cardiovascular diseases, inflammation, neurological diseases, and renal disease. Because Nrf2 is able to induce genes important in combating oxidative stress, thereby activating the body's own protective response, it is able to protect from a variety of oxidative stress-related complications, even in situations where the administration of exogenous antioxidants (such as Vitamin C and Vitamin E) have failed.

"What was really striking is that Nrf2 is a kind of master switch controlling the machinery of these antioxidant enzymes, and it appears the virus blocks its activity,” said senior author Dr. Roberto Garofalo, professor of pediatrics, microbiology, and immunology at the University of Texas Medical Branch. "This is interesting because genetic factors have been shown to be associated with other airway diseases, and the obvious question now is do the children who develop the most severe disease in response to RSV also have an Nrf2 gene that favors a low level of expression of these antioxidant enzymes? Are we seeing a combination of two hits, one from the virus, and one from genetics?”

Related Links:
University of Texas Medical Branch



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Urine Analyzer
respons® UDS100
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.